Yunnan Botanee Bio-Technology Group Co., Ltd. (300957.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 31.65

From 52W high−38.94%

Volume6.45M

Market capCNY 13.15B

P/E (TTM)26.0x

P/S (TTM)2.4x

Div yield2.06%

Key dataSep 18, 2026

Open

CNY 31.65

From 52W high

−38.94%

Volume

6.45M

Market cap

CNY 13.15B

ValuationView details →

P/E (Fwd)

38.5x

EV/EBITDA

15.1x

P/E (TTM)

26.0x

RSI (14)

44.4

MomentumView details →

1D Return

−1.99%

YTD Return

−20.25%

ValuationView details →

P/E (Fwd)

38.5x

P/E (TTM)

26.0x

EV/EBITDA

15.1x

EV/Sales

2.2x

P/S (TTM)

2.4x

P/B (TTM)

2.1x

ProfitabilityView details →

Gross Margin

73.72%

Net Margin

9.83%

EBITDA Margin

14.88%

ROE (TTM)

8.91%

ROA (TTM)

6.56%

Asset Turnover

0.66x

GrowthView details →

Revenue YoY

−1.07%

EPS YoY

+52.29%

FCF YoY

+794.71%

Revenue CAGR 3Y

+2.24%

EPS CAGR 3Y

−21.49%

EBITDA YoY

—

MomentumView details →

1D Return

−1.99%

YTD Return

−20.25%

1Y Return

−32.67%

RSI (14)

44.4

vs 50D SMA

−3.05%

vs 200D SMA

−16.39%

Capital & dividendView details →

Debt/Equity

0.14x

Current Ratio

3.63x

Quick Ratio

3.25x

Div Yield

2.06%

Div Rate

CNY 0.65

Div Growth 1Y

+8.33%

EarningsView details →

EPS (Actual)

CNY 0.52

EPS Surprise

−17.22%

Beats (12Q)

0/12

Next Q EPS Est

CNY 0.16

Avg Surprise (4Q)

−17.22%

Rev Surprise

−7.10%

Financials snapshotView financials →

Revenue (TTM)

5.53B

Net Income (TTM)

543.34M

Op. CF (TTM)

1.09B

Next earningsOct 28, 2026 →

Latest newsMore news →

Shanghai Botanee Health Technology, a wholly owned subsidiary of Botanee, received a medical device registration certificate from the National Medical Products Administration on September 10, 2026 for its injectable sodium hyaluronate solution.9d ago

Yunnan Botanee Bio-Technology Group disclosed that as of August 31, 2026, it had repurchased 3.6997 million shares for about 120 million yuan under its buyback program.18d ago

Similar companies

德方纳米300769.SZ 金富科技003018.SZ 联化科技002250.SZ 盛弘股份300693.SZ 高特电子301669.SZ 焦作万方000612.SZ Find similar companies →

Latest newsMore news →

Shanghai Botanee Health Technology, a wholly owned subsidiary of Botanee, received a medical device registration certificate from the National Medical Products Administration on September 10, 2026 for its injectable sodium hyaluronate solution.9d ago Yunnan Botanee Bio-Technology Group disclosed that as of August 31, 2026, it had repurchased 3.6997 million shares for about 120 million yuan under its buyback program.18d ago Botanee announced a share buyback alongside its interim dividend.27d ago